Multiple driver gene alterations defined as VHL mutation plus two or more additional mutations in PBRM1, SETD2, BAP1 or PTEN in analogy to (3) were detected in seven of 17 ccRCC patients (41.2%). The gene discussed is PTEN; the disease is nonpapillary renal cell carcinoma.